Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1986 Oct;23(2):93–100. doi: 10.1007/BF00199813

Circulating melanoma-associated antigen detected by monoclonal antibody NKI/C-3

Claudia Vennegoor 1,✉, Philip Rümke 1
PMCID: PMC11038752  PMID: 2430706

Abstract

NKI/C-3 and NKI/black-13 are monoclonal antibodies recognizing different epitopes on a melanoma-associated antigen that is preserved after fixation in formalin and embedding in paraffin in virtually all melanoma tissues. The antigen, a predominantly cytoplasmic vesicle membrane-bound heterogeneous glycoprotein of 25–110×103 daltons, was shown to be a single 25×103 dalton polypeptide when incorporation of N-linked carbohydrates was inhibited by tunicamycin. The antigen was measured in a double determinant enzyme immunoassay (DDEIA) using NKI/C-3 as catcher antibody. Results from in vitro experiments indicated that the antigen is actively shed from living cells. In sera from melanoma patients with a small tumor burden, the antigen concentrations were in the range of those of controls (0–22 U/ml). Significantly increased values (33–600 U/ml) were found in sera from patients with a moderate or large tumor burden. The antigen concentrations in sera from patients with multiple metastases of other tumors were within the range of controls. Several sera from patients with multiple metastases of colon, pancreatic, and stomach carcinoma, however, contained increased antigen concentrations (45–80 U/ml). These results correspond with the reactions of NKI/C-3 in tissue sections of some malignancies other than melanoma.

During the follow-up of melanoma patients the concentrations of circulating antigen correlated with tumor progression. The predictive value of the NKI/C-3 assay was no better than determination of serum lactate dehydrogenase, alkaline phosphatase or gamma glutamyl transferase activity.

Keywords: Melanoma Patient, Tunicamycin, Glutamyl, Gamma Glutamyl, Gamma Glutamyl Transferase

References

  • 1.Atkinson B, Ernst CS, Ghrist BFD, Ross AH, Clark WH, Herlyn M, Herlyn D, Maul G, Steplewski Z, Koprowski H. Monoclonal antibody to a highly glycosylated protein reacts in fixed tissue with melanoma and other tumors. Hybridoma. 1985;4:243. doi: 10.1089/hyb.1985.4.243. [DOI] [PubMed] [Google Scholar]
  • 2.Bayer EA, Skutelsky E, Wilchek M. The avidin-biotin complex in affinity cytochemistry. In: McCormick DB, Wright LD, editors. Methods in enzymology, vol 62. New York: Academic Press; 1979. p. 308. [DOI] [PubMed] [Google Scholar]
  • 3.Bos ES, Van der Doelen AA, Van Rooy N, Schuurs AHWM. 3,3',5,5'-Tetramethylbenzidine as an Ames test negative chromogen for horse-radish peroxidase in enzyme-immunoassay. J Immunoassay. 1981;2:187. doi: 10.1080/15321818108056977. [DOI] [PubMed] [Google Scholar]
  • 4.Buchegger F, Haskell CM, Carrel S, Rosenberger M, Testuz J, Mach J-P. Monoclonal antibodies and a streptavidinbiotin system used in an enzyme immunoassay for carcinoembryonic antigen. In: Peeters H, editor. Protides of the biological fluids, vol 31. Oxford: Pergamon Press; 1983. p. 1025. [Google Scholar]
  • 5.Dixon M, Webb EC, editors. Enzymes. Second Edition. London: Longmans Green and Co.; 1967. p. 337. [Google Scholar]
  • 6.Donoso LA, Folberg R, Edelberg K, Arbizo V, Atkinson B, Herlyn M. Tissue distribution and biochemical properties of an ocular melanoma-associated antigen. J Histochem Cytochem. 1985;33:1190. doi: 10.1177/33.12.3905953. [DOI] [PubMed] [Google Scholar]
  • 7.Fazekas de St Groth S, Scheidegger D. Production of monoclonal antibodies: strategy and tactics. J Immunol Methods. 1980;35:1. doi: 10.1016/0022-1759(80)90146-5. [DOI] [PubMed] [Google Scholar]
  • 8.Friguet B, Djavadi-Ohaniance L, Pages J, Bussard A, Goldberg M. A convenient enzyme-linked immunosorbent assay for testing whether monoclonal antibodies recognize the same antigenic site. Application to hybridomas specific for the β2-subunit of Escherichia coli tryptophan synthetase. J Immunol Methods. 1983;60:351. doi: 10.1016/0022-1759(83)90292-2. [DOI] [PubMed] [Google Scholar]
  • 9.Friguet B, Chaffotte AF, Djavadi-Ohanicance L, Goldberg ME. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J Immunol Methods. 1985;77:305. doi: 10.1016/0022-1759(85)90044-4. [DOI] [PubMed] [Google Scholar]
  • 10.Gallati H, Pracht I. Peroxidase aus Meerrettich: Kinetische Studien und Optimierung der Peroxidase-Aktivitätsbe-stimmung mit den Substraten H2O2 und 3,3',5,5'-Tetramethylbenzidin. J Clin Chem Clin Biochem. 1985;23:453. [PubMed] [Google Scholar]
  • 11.Giacomini P, Ng AK, Kantor RRS, Natali PG, Ferrone S. Double determinant immunoassay to measure a human high molecular weight melanoma-associated antigen. Cancer Res. 1983;43:3586. [PubMed] [Google Scholar]
  • 12.Giacomini P, Veglia F, Cordali Fei P, Rehle T, Natali PG, Ferrone S. Level of a membrane-bound high molecular weight melanoma-associated antigen and a cytoplasmic melanoma-associated antigen in surgically removed tissues and in sera from patients with melanoma. Cancer Res. 1984;44:1281. [PubMed] [Google Scholar]
  • 13.Hagen EC, Vennegoor C, Schlingemann RO, Van der Velde EA, Ruiter DJ (1986) Correlation of histopathological characteristics with staining patterns in human melanoma assessed by monoclonal antibodies reactive on paraffin sections. Histopathology (in press) [DOI] [PubMed]
  • 14.Harris JR. Some negative contrast staining features of a protein from erythrocyte ghosts. J Mol Biol. 1969;46:329. doi: 10.1016/0022-2836(69)90425-2. [DOI] [PubMed] [Google Scholar]
  • 15.Hudson L, Hay FC, editors. Practical immunology. Oxford: Blackwell Scientific Publications; 1976. p. 1. [Google Scholar]
  • 16.Ishii Y, Mavligit GM. Immunodiagnosis of human melanoma: characterization of human melanoma antigens and their detection in sera of melanoma patients by radioimmunoassay. Oncology. 1982;39:23. doi: 10.1159/000225598. [DOI] [PubMed] [Google Scholar]
  • 17.Kuroki M, Kuroki M, Ichiki S, Matsuoka Y. Identification and partial characterization of the unglycosylated peptide of carcinoembryonic antigen synthesized by human tumor cell lines in the presence of tunicamycin. Mol Immunol. 1984;21:743. doi: 10.1016/0161-5890(84)90028-2. [DOI] [PubMed] [Google Scholar]
  • 18.Laemmli U-K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  • 19.Lennarz WJ, editor. The biochemistry of glycoproteins and proteoglycans. New York: Plenum Publishing Corp.; 1980. p. 22. [Google Scholar]
  • 20.McKie RM, Campbell I, Turbitt ML. Use of NKI/C3 monoclonal antibody in the assessment of benign and malignant melanocytic lesions. J Clin Pathol. 1984;37:367. doi: 10.1136/jcp.37.4.367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Maeda K, Yamana K, Akutsu Y, Jimbow K. Structure and function of melanin, vol. 2. Sapporo: Fuji Printing; 1985. Development of a mouse monoclonal antibody, MoAb HMSA-2, against melanosomal proteins and distribution of antigen protein reactive with it by immunohistochemistry; p. 46. [Google Scholar]
  • 22.Morgan AC, Crane MM, Rossen RD. Measurement of a monoclonal antibody-defined, melanoma-associated antigen in human sera: correlation of circulating antigen levels with tumor burden. J Natl Cancer Inst. 1984;72:243. [PubMed] [Google Scholar]
  • 23.Palmer AA, Hall BE, Lew M. A comparison of some methods for identifying amelanotic and oligomelanotic melanoma metastases in paraffin sections. Pathology. 1985;17:335. doi: 10.3109/00313028509063776. [DOI] [PubMed] [Google Scholar]
  • 24.Ross AH, Herlyn M, Ernst CS, Guerry D, Bennicelli J, Ghrist BFD, Atkinson B, Koprowski H. Immunoassay for melanoma-associated proteoglycan in the sera of patients using monoclonal and polyclonal antibodies. Cancer Res. 1984;44:4642. [PubMed] [Google Scholar]
  • 25.Ross AH, Dietzschold B, Jackson DM, Earley JJ, Ghrist BDF, Atkinson B, Koprowski H. Isolation and amino terminal sequencing of a novel melanoma-associated antigen. Arch Biochem Biophys. 1985;242:540. doi: 10.1016/0003-9861(85)90241-3. [DOI] [PubMed] [Google Scholar]
  • 26.Taniguchi N, Iizuka S, Zhe ZN, House S, Yokosawa N, Ono M, Kinoshita K, Makita A, Sekiya C. Measurement of human serum immunoreactive γ-glutamyl transpeptidase in patients with malignant tumors using enzyme-linked immunosorbent assay. Cancer Res. 1985;45:5835. [PubMed] [Google Scholar]
  • 27.Van Duinen SG, Ruiter DJ, Hageman Ph, Vennegoor C, Dickersin GR, Scheffer E, Rümke Ph. Immunohistochemical and histochemical tools in the diagnosis of amelanotic melanoma. Cancer. 1984;53:1566. doi: 10.1002/1097-0142(19840401)53:7<1566::aid-cncr2820530724>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 28.Vennegoor C, Calafat J, Hageman Ph, Van Buitenen F, Janssen H, Kolk A, Rümke Ph. Biochemical characterization and cellular localization of a formalin-resistant melanoma-associated antigen reacting with monoclonal antibody NKI/C-3. Int J Cancer. 1985;35:287. doi: 10.1002/ijc.2910350302. [DOI] [PubMed] [Google Scholar]
  • 29.Wilson DF, Erecinska M. Methods of enzymology, vol LIII. London: Academic Press; 1978. Ligands of cytochrome c oxidase; p. 191. [DOI] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES